123 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
22 Recruiting A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve
Conditions: Anticoagulation Treatment Overdose;   Heart Valve Diseases
Interventions: Other: Genotype-based Warfarin Initiation model;   Other: clinical factor-based warfarin initiation model
23 Not yet recruiting Model-based Versus Traditional Warfarin Dosing in Children
Condition: Congenital Heart Defects
Interventions: Device: Warfarin Dosing Aid;   Other: Standard Practice
24 Recruiting Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Conditions: Ischemic Stroke;   Transient Ischemic Attack
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
25 Recruiting Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
Condition: Atrial Fibrillation
Interventions: Drug: Warfarin;   Drug: Dabigatran Etexilate 150mg
26 Not yet recruiting Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
Condition: Healthy
Interventions: Drug: PEX168;   Drug: Warfarin
27 Not yet recruiting Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
28 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
29 Not yet recruiting Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
Conditions: Post Polypectomy Bleeding in Anticoagulated Patients;   Gastrointestinal Hemorrhage
Interventions: Drug: Warfarin;   Drug: LMW Heparin
30 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
31 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
32 Recruiting Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Condition: Atherosclerosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
33 Recruiting Statin Use in Patients With Acute VTE
Condition: Venous Thromboembolism
Interventions: Drug: Atorvastatin;   Drug: Warfarin
34 Not yet recruiting EdoxabaN or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Edoxaban;   Drug: Warfarin
35 Recruiting Evaluation of Wound Drainage After Knee or Hip Arthroplasty
Condition: Complications; Arthroplasty
Interventions: Drug: Rivaroxaban (Xarelto);   Drug: Warfarin (Coumadin)
36 Recruiting The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke
Conditions: Cardioembolic Stroke;   Atrial Fibrillation
Interventions: Drug: aspirin plus hirudin;   Drug: Warfarin
37 Not yet recruiting XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
Conditions: Pulmonary Embolism;   Venous Thrombosis
Interventions: Drug: rivaroxaban;   Drug: warfarin
38 Recruiting Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation
Conditions: Coronary Artery Disease;   Atrial Fibrillation;   Stroke;   Fetal Blood Loss
Intervention: Drug: Warfarin or Rivaroxaban
39 Unknown  The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin
40 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years